Tag: synthetic cannabinoids market size

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Synthetic Cannabinoids Market Size Outlook: How Quickly Will Revenue Expand Through 2030?

The synthetic cannabinoids market has witnessed a rapid expansion in recent years. It is anticipated to increase from $2.2 billion in 2025 to $2.59 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 17.6%. This historical growth can be linked to various factors such as the constraints of plant-derived cannabinoids, the need for potency control, pharmaceutical research requirements, the rise of pain management therapies, and regulatory approvals in specific areas.

The synthetic cannabinoids market size is expected to experience significant expansion in the coming years. It is projected to increase to $4.91 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.4%. This growth during the forecast period is attributable to the expansion of medical cannabis, the development of controlled cannabinoid therapeutics, the demand for precision dosing, the scalability of synthetic APIs, and investments in pharmaceutical R&D. Prominent trends for this period include the broadening of pharmaceutical-grade cannabinoids, an increasing use of synthetic cannabinoids in research, a rising need for high-purity formulations, a move towards regulated medical applications, and progress in controlled synthesis techniques.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=63687844&type=smp&name=Synthetic%20Cannabinoids%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Synthetic Cannabinoids Market Demand Drivers Opening New Revenue Streams

The increasing requirement for treatments for neurological disorders is anticipated to stimulate the future growth of the synthetic cannabinoids market. These conditions involve diseases of the brain, spinal cord, and nerves that disrupt movement, sensation, cognition, or overall functioning. The expanding prevalence of neurological disorders is primarily linked to the aging global population, as conditions such as Alzheimer’s become more common with age due to brain aging and accumulated cellular damage. Synthetic cannabinoids act on cannabinoid receptors in the brain, assisting in the regulation of neurotransmitter activity and potentially easing symptoms related to neurological disorders. For instance, in September 2024, the European Brain Council, a Belgium-based health organization, reported that 7 million people in Europe are currently living with Alzheimer’s disease, a figure expected to double to 14 million by 2030 due to an aging population, establishing it as a significant global public health challenge. Thus, the escalating demand for neurological disorder treatments is propelling the growth of the synthetic cannabinoids market.

Synthetic Cannabinoids Market Segment Analysis Spotlighting Growth Areas

The synthetic cannabinoids market covered in this report is segmented –

1) By Product Type: High-Pure Synthetic Cannabinoids, Ultra-Pure Synthetic Cannabinoids

2) By Formulation: Oil, Capsules, Edibles, Vapes, Topicals

3) By Indication: Pain Management, Nausea Or Vomiting, Neurological Disorder Management, Other Indications

4) By Application: Pharmaceuticals, Research, Recreational Use, Agriculture, Nutraceuticals

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By High-Pure Synthetic Cannabinoids: Pharmaceutical-Grade Cannabinoids, Research-Grade Cannabinoids, Industrial-Use Cannabinoids

2) By Ultra-Pure Synthetic Cannabinoids: Medical-Grade Cannabinoids, Biotechnology-Grade Cannabinoids, Analytical-Standard Cannabinoids

Synthetic Cannabinoids Market Trends Powering Strategic Industry Growth

Leading companies in the synthetic cannabinoids market are concentrating on producing safer, high-quality products, such as novel psychoactive substances, to diminish health risks and reinforce their market competitiveness. Novel psychoactive substances are laboratory-engineered designer drugs that imitate the effects of traditional illicit substances but incorporate modified chemical structures to avoid detection and regulation. For example, Quest Diagnostics Inc., a US-based healthcare firm, introduced an 88-compound Novel Psychoactive Substance (NPS) Test Panel in December 2023. This panel aims to more accurately identify a broad spectrum of synthetic cannabinoids and other designer drugs. This new mass-spectrometry-based test offers improved detection of evolving synthetic cannabinoids, assisting healthcare providers in understanding patient exposure more clearly and making better treatment decisions. The availability of such advanced testing solutions underscores the increasing requirement for trustworthy monitoring tools as synthetic cannabinoids continue to develop, thereby ensuring heightened safety, transparency, and regulatory adherence within the market.

Synthetic Cannabinoids Market Leading Companies: Who Holds The Strongest Market Presence?

Major companies operating in the synthetic cannabinoids market are Cayman Chemical, Cerilliant Corporation, Restek Corporation, Chiron AS, BayMedica, CB Therapeutics Inc., Skye Bioscience, Zynerba Pharmaceuticals Inc., Botanix Pharmaceuticals, Kannalife Sciences Inc., SciSparc Ltd., Tetra Bio-Pharma Inc., Canntab Therapeutics Ltd., BioVectra, Noramco Inc., Purisys LLC, Lygos Inc., Johnson Matthey, Almac Group, Cambrex Corporation

View The Full Synthetic Cannabinoids Market Report:

https://thebusinessresearchcompany.com/report/synthetic-cannabinoids-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Synthetic Cannabinoids Market Regional Analysis: Which Geography Leads On Revenue?

North America was the largest region in the synthetic cannabinoids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic cannabinoids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Synthetic Cannabinoids Market Growth From $2.58 Billion In 2026 To $4.9 Billion By 2030 At A CAGR Of 17.4%

Between 2025 and 2026, the synthetic cannabinoids market is expected to experience substantial expansion, rising from $2.2 billion to $2.59 billion, marking a compound annual growth rate (CAGR) of 17.6%. This rapid growth in recent years was driven historically by several key factors: the constraints associated with plant-derived cannabinoids, a desire for precise potency control, requirements arising from pharmaceutical research, an increase in pain management treatments, and regulatory approvals granted in specific areas.

Over the coming years, the synthetic cannabinoids market is anticipated to experience swift expansion, reaching a projected $4.91 billion by 2030 with a compound annual growth rate (CAGR) of 17.4%. This forecasted growth is driven by factors such as the broadening of medical cannabis applications, the rise of regulated cannabinoid-based therapies, the need for precise dosing, the scalability of synthetic active pharmaceutical ingredients (APIs), and increased funding for pharmaceutical research and development. Key trends shaping this period include the growing availability of pharmaceutical-grade cannabinoids, heightened research utilization of synthetic variants, a surge in demand for high-purity products, a transition toward medically regulated uses, and progress in controlled synthesis methods.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23536&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

#Synthetic Cannabinoids Market Growth Factors: Which Forces Are Supporting Market Expansion?

The growing need for therapies addressing neurological conditions is anticipated to drive forward the expansion of the synthetic cannabinoids market. Neurological disorders involve the brain, spinal cord, and nerves, disrupting movement, sensation, cognition, or overall functioning. Their increasing prevalence stems mainly from an aging worldwide population, as age-related conditions like Alzheimer’s become more frequent due to brain deterioration and cumulative cellular damage over time. Synthetic cannabinoids work by targeting cannabinoid receptors within the brain, thereby modulating neurotransmitter activity and potentially relieving symptoms tied to these disorders. As an illustration, the European Brain Council, a health organization based in Belgium, reported in September 2024 that approximately 7 million individuals across Europe currently have Alzheimer’s disease. This figure is projected to double to 14 million by 2030, driven by demographic aging and presenting a substantial global public health concern. Consequently, the heightened demand for neurological disorder treatments is fueling growth within the synthetic cannabinoids market.

Synthetic Cannabinoids Market Segmentation Trends And Revenue Drivers

The synthetic cannabinoids market covered in this report is segmented –

1) By Product Type: High-Pure Synthetic Cannabinoids, Ultra-Pure Synthetic Cannabinoids

2) By Formulation: Oil, Capsules, Edibles, Vapes, Topicals

3) By Indication: Pain Management, Nausea Or Vomiting, Neurological Disorder Management, Other Indications

4) By Application: Pharmaceuticals, Research, Recreational Use, Agriculture, Nutraceuticals

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By High-Pure Synthetic Cannabinoids: Pharmaceutical-Grade Cannabinoids, Research-Grade Cannabinoids, Industrial-Use Cannabinoids

2) By Ultra-Pure Synthetic Cannabinoids: Medical-Grade Cannabinoids, Biotechnology-Grade Cannabinoids, Analytical-Standard Cannabinoids

Synthetic Cannabinoids Market Industry Trends: What Changes Are Reshaping Demand?

Leading players in the synthetic cannabinoids market are prioritizing the creation of safer, premium-grade products, including novel psychoactive substances, in order to minimize health hazards and enhance their market position. Novel psychoactive substances are synthetic drugs produced in laboratories that replicate the effects of traditional illegal substances but rely on altered chemical compositions to avoid regulation and detection. For example, in December 2023, Quest Diagnostics Inc., a healthcare firm based in the United States, unveiled an advanced 88-compound Novel Psychoactive Substance (NPS) Test Panel aimed at more precisely detecting a broad spectrum of synthetic cannabinoids and other designer drugs. This mass-spectrometry-based test facilitates clearer identification of emerging synthetic cannabinoids, enabling healthcare professionals to gain a better understanding of patient exposure and to refine treatment strategies. The rollout of such sophisticated testing solutions underscores the escalating demand for dependable monitoring instruments as synthetic cannabinoids keep evolving, thereby fostering enhanced safety, openness, and regulatory adherence throughout the sector.

Synthetic Cannabinoids Market Industry Leaders: Which Organizations Are Driving Competition?

Major companies operating in the synthetic cannabinoids market are Cayman Chemical, Cerilliant Corporation, Restek Corporation, Chiron AS, BayMedica, CB Therapeutics Inc., Skye Bioscience, Zynerba Pharmaceuticals Inc., Botanix Pharmaceuticals, Kannalife Sciences Inc., SciSparc Ltd., Tetra Bio-Pharma Inc., Canntab Therapeutics Ltd., BioVectra, Noramco Inc., Purisys LLC, Lygos Inc., Johnson Matthey, Almac Group, Cambrex Corporation

Access The Complete Synthetic Cannabinoids Market Report:

https://www.thebusinessresearchcompany.com/report/synthetic-cannabinoids-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Synthetic Cannabinoids Market Regional Analysis And Leading Geography

North America was the largest region in the synthetic cannabinoids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic cannabinoids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Value Trend Is Expected For The Synthetic Cannabinoids Market From 2026 To 2030?

The market for synthetic cannabinoids has experienced substantial expansion in recent times. This market is projected to expand from $2.2 billion in 2025 to $2.59 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 17.6%. Key factors contributing to its historical growth include the constraints of plant-derived cannabinoids, the necessity for potency regulation, requirements for pharmaceutical research, the rise in pain management treatments, and specific regional regulatory acceptances.

The synthetic cannabinoids market size is projected to experience substantial growth in the upcoming years. It is anticipated to reach a valuation of $4.91 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.4%. This projected expansion during the forecast period is due to factors such as the broader availability of medical cannabis, the rise in controlled cannabinoid therapeutics, the need for precision dosing, the scalability of synthetic APIs, and increased pharmaceutical R&D investments. Significant developments expected in this period encompass the spread of pharmaceutical-grade cannabinoids, expanding research into synthetic cannabinoids, a rising need for high-purity products, a move towards regulated medical applications, and improvements in controlled synthesis methods.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23536&type=smp

Which Growth Factors Are Strengthening The Synthetic Cannabinoids Market Landscape?

The escalating requirement for treatments targeting neurological disorders is projected to propel the future expansion of the synthetic cannabinoids market. These conditions encompass diseases of the brain, spinal cord, and nerves, which disrupt movement, sensation, cognition, or overall bodily function. The rising occurrence of neurological disorders is predominantly attributed to the global aging population, as ailments like Alzheimer’s grow more prevalent with age due to cerebral aging and cumulative cellular damage. Synthetic cannabinoids engage cannabinoid receptors in the brain, aiding in the regulation of neurotransmitter activity and potentially mitigating symptoms linked to neurological disorders. For example, in September 2024, the European Brain Council, a health organization based in Belgium, reported that 7 million people in Europe currently live with Alzheimer’s disease, a figure expected to double to 14 million by 2030 due to an aging population, making it a considerable global public health challenge. Consequently, the increasing demand for neurological disorder treatments is driving the growth of the synthetic cannabinoids market.

What Segment Types Are Included In The Synthetic Cannabinoids Market Analysis?

The synthetic cannabinoids market covered in this report is segmented –

1) By Product Type: High-Pure Synthetic Cannabinoids, Ultra-Pure Synthetic Cannabinoids

2) By Formulation: Oil, Capsules, Edibles, Vapes, Topicals

3) By Indication: Pain Management, Nausea Or Vomiting, Neurological Disorder Management, Other Indications

4) By Application: Pharmaceuticals, Research, Recreational Use, Agriculture, Nutraceuticals

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By High-Pure Synthetic Cannabinoids: Pharmaceutical-Grade Cannabinoids, Research-Grade Cannabinoids, Industrial-Use Cannabinoids

2) By Ultra-Pure Synthetic Cannabinoids: Medical-Grade Cannabinoids, Biotechnology-Grade Cannabinoids, Analytical-Standard Cannabinoids

Which Trends Are Contributing To Changes In The Synthetic Cannabinoids Market?

Key players within the synthetic cannabinoids market are concentrating their efforts on creating secure and superior products, including novel psychoactive substances, with the aim of minimizing associated health dangers and enhancing their market standing. Novel psychoactive substances are defined as designer drugs fabricated in laboratories, designed to imitate the effects of conventional illegal drugs, yet employing modified chemical structures to bypass detection and regulatory oversight. Illustratively, in December 2023, Quest Diagnostics Inc., a US-based healthcare company, introduced an innovative 88-compound Novel Psychoactive Substance (NPS) Test Panel, facilitating more precise identification of various synthetic cannabinoids and other designer drugs. This novel mass-spectrometry-based testing solution offers enhanced detection for evolving synthetic cannabinoids, thereby assisting healthcare providers in gaining a clearer comprehension of patient exposure and optimizing treatment choices. The implementation of these advanced diagnostic tools underscores an increasing demand for dependable monitoring mechanisms as synthetic cannabinoids continue their progression, thereby guaranteeing elevated safety, clarity, and adherence to regulations throughout the market.

Who Are The Businesses Driving Activity In The Synthetic Cannabinoids Market?

Major companies operating in the synthetic cannabinoids market are Cayman Chemical, Cerilliant Corporation, Restek Corporation, Chiron AS, BayMedica, CB Therapeutics Inc., Skye Bioscience, Zynerba Pharmaceuticals Inc., Botanix Pharmaceuticals, Kannalife Sciences Inc., SciSparc Ltd., Tetra Bio-Pharma Inc., Canntab Therapeutics Ltd., BioVectra, Noramco Inc., Purisys LLC, Lygos Inc., Johnson Matthey, Almac Group, Cambrex Corporation

Access The Complete Synthetic Cannabinoids Market Report:

https://www.thebusinessresearchcompany.com/report/synthetic-cannabinoids-global-market-report

Which Region Accounts For The Highest Share Of The Synthetic Cannabinoids Market?

North America was the largest region in the synthetic cannabinoids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic cannabinoids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Synthetic Cannabinoids Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=23536&type=smp

Browse Through More Reports Similar to the Global Synthetic Cannabinoids Market 2026, By The Business Research Company

Cannabinoids Market Report 2026

https://www.thebusinessresearchcompany.com/report/cannabinoids-global-market-report

Cannabis Capsule Market Report 2026

https://www.thebusinessresearchcompany.com/report/cannabis-capsule-global-market-report

Cannabis Extract Market Report 2026

https://www.thebusinessresearchcompany.com/report/cannabis-extract-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Synthetic Cannabinoids Market Projected To Become By 2030 Based On Its 2026 Valuation?

The synthetic cannabinoids market size has experienced rapid expansion in recent years. This market is projected to expand from $2.2 billion in 2025 to $2.59 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 17.6%. Historically, this growth can be ascribed to several factors, including the limitations of plant-derived cannabinoids, the increasing demand for potency control, specific pharmaceutical research needs, the rise in pain management therapies, and the attainment of regulatory approvals in certain regions.

The synthetic cannabinoids market is projected to undergo substantial expansion in the coming years. Its valuation is set to reach $4.91 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.4%. This anticipated growth during the forecast period is primarily driven by factors such as the broadening of medical cannabis applications, the rise of controlled cannabinoid therapies, the increasing need for precision dosing, the scalability of synthetic active pharmaceutical ingredients (APIs), and increased pharmaceutical research and development investments. Furthermore, key trends expected during this period involve the wider availability of pharmaceutical-grade cannabinoids, enhanced research applications of synthetic cannabinoids, a surge in the requirement for high-purity formulations, a move towards regulated medical uses, and progress in controlled synthesis methodologies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23536&type=smp

What Primary Drivers Are Shaping The Development Of The Synthetic Cannabinoids Market?

The increasing need for treatments for neurological disorders is anticipated to propel the expansion of the synthetic cannabinoids market going forward. Neurological disorders are diseases affecting the brain, spinal cord, and nerves that can impair movement, sensation, cognition, or overall body function. The growing prevalence of neurological disorders is primarily due to the global aging population, as conditions such as Alzheimer’s become more common with advancing age owing to brain aging and accumulated cellular damage. Synthetic cannabinoids specifically target cannabinoid receptors in the brain, aiding in the regulation of neurotransmitter activity and potentially mitigating symptoms linked to neurological disorders. For example, in September 2024, data from the European Brain Council, a health organization based in Belgium, indicated that 7 million people in Europe currently live with Alzheimer’s disease, a figure expected to reach 14 million by 2030 due to an aging population, thereby posing a substantial global public health challenge. Consequently, the rising demand for neurological disorder treatments is driving the growth of the synthetic cannabinoids market.

What Segment Groups Are Identified Within The Synthetic Cannabinoids Market?

The synthetic cannabinoids market covered in this report is segmented –

1) By Product Type: High-Pure Synthetic Cannabinoids, Ultra-Pure Synthetic Cannabinoids

2) By Formulation: Oil, Capsules, Edibles, Vapes, Topicals

3) By Indication: Pain Management, Nausea Or Vomiting, Neurological Disorder Management, Other Indications

4) By Application: Pharmaceuticals, Research, Recreational Use, Agriculture, Nutraceuticals

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By High-Pure Synthetic Cannabinoids: Pharmaceutical-Grade Cannabinoids, Research-Grade Cannabinoids, Industrial-Use Cannabinoids

2) By Ultra-Pure Synthetic Cannabinoids: Medical-Grade Cannabinoids, Biotechnology-Grade Cannabinoids, Analytical-Standard Cannabinoids

What Trends Are Advancing Progress In The Synthetic Cannabinoids Market?

Major companies operating in the synthetic cannabinoids market are concentrating on creating safer, high-quality products, such as novel psychoactive substances, to mitigate health risks and bolster their competitive standing. Novel psychoactive substances refer to laboratory-engineered designer drugs that replicate the effects of conventional illicit substances but utilize altered chemical structures to bypass detection and regulation. For instance, in December 2023, Quest Diagnostics Inc., a US-based healthcare company, unveiled a new 88-compound Novel Psychoactive Substance (NPS) Test Panel to aid in more precisely identifying a broad spectrum of synthetic cannabinoids and other designer drugs. This advanced mass-spectrometry-based test offers clearer identification of emerging synthetic cannabinoids, enabling healthcare providers to better comprehend patient exposure and refine treatment decisions. The introduction of such sophisticated testing solutions emphasizes the increasing necessity for reliable monitoring tools as synthetic cannabinoids continue to evolve, ensuring enhanced safety, transparency, and regulatory compliance across the market.

Which Companies Hold Significant Positions In The Synthetic Cannabinoids Market?

Major companies operating in the synthetic cannabinoids market are Cayman Chemical, Cerilliant Corporation, Restek Corporation, Chiron AS, BayMedica, CB Therapeutics Inc., Skye Bioscience, Zynerba Pharmaceuticals Inc., Botanix Pharmaceuticals, Kannalife Sciences Inc., SciSparc Ltd., Tetra Bio-Pharma Inc., Canntab Therapeutics Ltd., BioVectra, Noramco Inc., Purisys LLC, Lygos Inc., Johnson Matthey, Almac Group, Cambrex Corporation

Read the full synthetic cannabinoids market report here:

https://www.thebusinessresearchcompany.com/report/synthetic-cannabinoids-global-market-report

How Does The Synthetic Cannabinoids Market Perform Across Major Global Regions?

North America was the largest region in the synthetic cannabinoids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic cannabinoids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Synthetic Cannabinoids Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=23536&type=smp

Browse Through More Reports Similar to the Global Synthetic Cannabinoids Market 2026, By The Business Research Company

Cannabinoids Market Report 2026

https://www.thebusinessresearchcompany.com/report/cannabinoids-global-market-report

Cannabis Capsule Market Report 2026

https://www.thebusinessresearchcompany.com/report/cannabis-capsule-global-market-report

Cannabis Extract Market Report 2026

https://www.thebusinessresearchcompany.com/report/cannabis-extract-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the synthetic cannabinoids market from 2026–2035 with trusted insights from The Business Research Company

What is the estimated market size of the Synthetic Cannabinoids Market by the end of 2030?

The synthetic cannabinoids market has seen substantial growth in its size over recent years. It is anticipated to increase from $2.2 billion in 2025 to $2.59 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 17.6%. Historically, this expansion has been driven by the limitations of plant-derived cannabinoids, a rising demand for potency control, needs in pharmaceutical research, the development of pain management therapies, and various regulatory approvals within specific regions.

The synthetic cannabinoids market is projected for significant expansion over the coming years, reaching $4.91 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 17.4%. This anticipated growth is driven by factors such as the increasing reach of medical cannabis, the development of controlled cannabinoid therapeutics, the need for precision dosing, the scalability of synthetic active pharmaceutical ingredients (APIs), and substantial pharmaceutical research and development investments. Key trends expected during this period involve the wider availability of pharmaceutical-grade cannabinoids, the rising application of synthetic cannabinoids in research, a heightened call for high-purity formulations, a move towards regulated medical uses, and improvements in controlled synthesis methods.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23536&type=smp

What Drivers Are Shaping Future Opportunities In The Synthetic Cannabinoids Market?

The future expansion of the synthetic cannabinoids market is anticipated due to an escalating need for treatments addressing neurological disorders. These conditions encompass ailments affecting the brain, spinal cord, and nerves, which disrupt movement, sensation, cognitive abilities, or overall bodily functions. The growing incidence of neurological disorders is primarily linked to the global aging population, as conditions such as Alzheimer’s become more common with advancing age due to brain aging and accumulated cellular damage. Synthetic cannabinoids specifically target cannabinoid receptors within the brain, assisting in the regulation of neurotransmitter activity and potentially alleviating symptoms associated with neurological disorders. For instance, in September 2024, according to the European Brain Council, a Belgium-based health organization, 7 million people in Europe currently live with Alzheimer’s disease, a number expected to double to 14 million by 2030 due to an aging population, making it a significant global public health challenge. Consequently, the rising demand for neurological disorder treatments is driving the growth of the synthetic cannabinoids market.

Which Segments Are Gaining Traction In The Synthetic Cannabinoids Market?

The synthetic cannabinoids market covered in this report is segmented –

1) By Product Type: High-Pure Synthetic Cannabinoids, Ultra-Pure Synthetic Cannabinoids

2) By Formulation: Oil, Capsules, Edibles, Vapes, Topicals

3) By Indication: Pain Management, Nausea Or Vomiting, Neurological Disorder Management, Other Indications

4) By Application: Pharmaceuticals, Research, Recreational Use, Agriculture, Nutraceuticals

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By High-Pure Synthetic Cannabinoids: Pharmaceutical-Grade Cannabinoids, Research-Grade Cannabinoids, Industrial-Use Cannabinoids

2) By Ultra-Pure Synthetic Cannabinoids: Medical-Grade Cannabinoids, Biotechnology-Grade Cannabinoids, Analytical-Standard Cannabinoids

Which Innovation Trends Are Advancing Developments Within The Synthetic Cannabinoids Market?

Leading companies within the synthetic cannabinoids market are concentrating on creating safer, superior products, including novel psychoactive substances, with the aim of mitigating health hazards and enhancing their market standing. Novel psychoactive substances are defined as designer drugs crafted in laboratories that imitate the effects of traditional illegal drugs, yet possess modified chemical structures to bypass detection and regulatory oversight. As an illustration, in December 2023, Quest Diagnostics Inc., a healthcare firm based in the US, introduced an 88-compound Novel Psychoactive Substance (NPS) Test Panel. This panel is designed to more accurately pinpoint a broad spectrum of synthetic cannabinoids and other designer drugs. The mass-spectrometry-based test offers enhanced clarity in identifying newly emerging synthetic cannabinoids, thereby assisting healthcare providers in better comprehending patient exposure and making more informed treatment choices. The deployment of such sophisticated testing innovations underscores the increasing demand for dependable monitoring instruments as synthetic cannabinoids continue to develop, thereby guaranteeing enhanced safety, clarity, and adherence to regulations throughout the market.

Who Are The Top-Performing Companies In The Synthetic Cannabinoids Market In Recent Years?

Major companies operating in the synthetic cannabinoids market are Cayman Chemical, Cerilliant Corporation, Restek Corporation, Chiron AS, BayMedica, CB Therapeutics Inc., Skye Bioscience, Zynerba Pharmaceuticals Inc., Botanix Pharmaceuticals, Kannalife Sciences Inc., SciSparc Ltd., Tetra Bio-Pharma Inc., Canntab Therapeutics Ltd., BioVectra, Noramco Inc., Purisys LLC, Lygos Inc., Johnson Matthey, Almac Group, Cambrex Corporation

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/synthetic-cannabinoids-global-market-report

Which Region Currently Holds The Largest Share Of The Synthetic Cannabinoids Market?

North America was the largest region in the synthetic cannabinoids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic cannabinoids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Synthetic Cannabinoids Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=23536&type=smp

Browse Through More Reports Similar to the Global Synthetic Cannabinoids Market 2026, By The Business Research Company

Cannabinoids Market Report 2026

https://www.thebusinessresearchcompany.com/report/cannabinoids-global-market-report

Cannabis Capsule Market Report 2026

https://www.thebusinessresearchcompany.com/report/cannabis-capsule-global-market-report

Cannabis Extract Market Report 2026

https://www.thebusinessresearchcompany.com/report/cannabis-extract-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the calcium gluconate market from 2025–2034 with trusted insights from The Business Research Company

What Is The Base Market Size For The Calcium Gluconate Market Today And What Will It Reach By 2029?

The synthetic cannabinoids market has seen swift expansion in recent times. Its value is forecast to rise from $1.88 billion in 2024 to $2.2 billion in 2025, reflecting a compound annual growth rate (CAGR) of 17.1%. The increase observed in the past can be ascribed to a heightened need for alternative drugs, a rise in cannabis users, expanding pharmaceutical uses, an increasing desire for legal highs, and a growing inclination towards self-medication.

The synthetic cannabinoids market size is anticipated to undergo rapid expansion in the upcoming years, projected to reach $4.19 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 17.5%. This growth throughout the forecast period stems from factors such as the increasing appeal of designer drugs, the expanding legalization of cannabis, enhanced online availability of synthetic drugs, the rising prevalence of vaping, and greater customization in cannabinoid products. Significant trends expected during this period involve advanced forensic toxicology techniques, the utilization of machine learning for chemical pattern recognition, cloud-based systems for tracking illicit drugs, novel developments in synthetic cannabinoid formulations, and the creation of new cannabinoid analogs.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23536&type=smp

What Factors Are Boosting The Calcium Gluconate Market?

An increasing need for treatments addressing neurological disorders is projected to boost the expansion of the synthetic cannabinoids market in the future. These disorders encompass conditions affecting the brain, spinal cord, and nerves, leading to impairments in movement, sensation, thought processes, or general bodily functions. The rising occurrence of neurological disorders is largely attributable to the aging worldwide population, given that conditions like Alzheimer’s become more frequent with advancing age, a result of brain senescence and cellular accumulation damage. Synthetic cannabinoids operate by targeting specific receptors in the brain, which assists in modulating neurotransmitter activity and may offer relief from symptoms linked to neurological conditions. As an illustration, the European Brain Council, a health organization based in Belgium, reported in September 2024 that 7 million individuals in Europe presently suffer from Alzheimer’s disease. This figure is anticipated to increase to 14 million by 2030, driven by the aging demographic, thereby posing a substantial global public health issue. Consequently, the growing requirement for therapies for neurological disorders is fueling the expansion of the synthetic cannabinoids market.

How Is The Calcium Gluconate Market Categorized By Application, Type, And Region?

The synthetic cannabinoids market covered in this report is segmented –

1) By Product Type: High-Pure Synthetic Cannabinoids, Ultra-Pure Synthetic Cannabinoids

2) By Formulation: Oil, Capsules, Edibles, Vapes, Topicals

3) By Indication: Pain Management, Nausea Or Vomiting, Neurological Disorder Management, Other Indications

4) By Application: Pharmaceuticals, Research, Recreational Use, Agriculture, Nutraceuticals

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By High-Pure Synthetic Cannabinoids: Pharmaceutical-Grade Cannabinoids, Research-Grade Cannabinoids, Industrial-Use Cannabinoids

2) By Ultra-Pure Synthetic Cannabinoids: Medical-Grade Cannabinoids, Biotechnology-Grade Cannabinoids, Analytical-Standard Cannabinoids

How Are Technological Trends Affecting The Calcium Gluconate Market Growth?

Leading companies within the synthetic cannabinoids market are concentrating on developing sophisticated solutions, including fungal expression systems, to improve production efficiency and decrease expenses. Fungal expression systems leverage genetically modified fungi to create synthetic cannabinoids through biosynthesis, presenting an eco-friendly and scalable substitute for chemical synthesis or plant extraction. These systems facilitate the production of high-purity compounds for both pharmaceutical and research purposes. For example, in January 2022, Dyadic International Inc., a US biotechnology company, introduced a C1-cell protein production platform designed for manufacturing synthetic cannabinoids. This innovative strategy harnesses filamentous fungal cell factories to produce cannabinoids like cannabidiol (CBD) and their precursors more economically and sustainably. The process is environmentally sound, energy-efficient, and capable of generating purer, regulatory-compliant cannabinoids with prospective therapeutic applications in areas such as chronic pain, inflammation, and other medical conditions.

Who Are The Global Leaders Steering The Calcium Gluconate Market Forward?

Major companies operating in the synthetic cannabinoids market are Johnson Matthey, Harmony Biosciences, BioVectra, Restek Corporation, Noramco Inc., Cayman Chemical, Cerilliant Corporation, Skye Bioscience, Purisys LLC, Chiron AS, Lygos Inc., Botanix Pharmaceuticals, CB Therapeutics Inc., BayMedica, Zynerba Pharmaceuticals Inc., Kannalife Sciences Inc., SciSparc Ltd., 180 Life Science, Tetra Bio-Pharma Inc., Canntab Therapeutics Ltd.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/synthetic-cannabinoids-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Calcium Gluconate Market?

North America was the largest region in the synthetic cannabinoids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic cannabinoids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=23536&type=smp

Browse Through More Reports Similar to the Global Calcium Gluconate Market 2025, By The Business Research Company

Cannabinoids Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cannabinoids-global-market-report

Synthetic Rubber And Fibers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/synthetic-rubber-and-fibers-global-market-report

Synthetic Dyes Market 2025

https://www.thebusinessresearchcompany.com/report/synthetic-dyes-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Anticipated Size Of The Synthetic Cannabinoids Market Over The Five-Year Period 2025–2029?

The synthetic cannabinoids market has experienced rapid expansion in recent years. It is projected to grow from $1.88 billion in 2024 to $2.2 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 17.1%. The market’s historic growth is attributable to factors such as increasing demand for alternative drugs, increasing number of cannabis users, growing pharmaceutical applications, growing demand for legal highs, and a growing shift toward self-medication.

The market size for synthetic cannabinoids is anticipated to observe significant expansion over the next few years, with projections indicating growth to $4.19 billion by 2029, achieving a compound annual growth rate (CAGR) of 17.5%. This forecasted growth is largely attributable to the escalating popularity of designer drugs, the increasing legalization of cannabis, enhanced online access to synthetic drugs, the rising prevalence of vaping, and the growing customization possibilities for cannabinoid products. Prominent trends within this forecast period include the adoption of advanced forensic toxicology techniques, the utilization of machine learning for chemical pattern recognition, the implementation of cloud-based systems for illicit drug tracking, continuous innovations in synthetic cannabinoid formulations, and the ongoing development of novel cannabinoid analogs.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23536&type=smp

What Are The Key Drivers Of Growth In The Synthetic Cannabinoids Market?

The escalating need for treatments addressing neurological disorders is anticipated to fuel the expansion of the synthetic cannabinoids market in the future. These disorders encompass conditions affecting the brain, spinal cord, and nerves, leading to impairments in movement, sensation, cognitive abilities, or general bodily function. The growing occurrence of neurological disorders largely stems from the world’s aging populace, given that conditions like Alzheimer’s become more prevalent as individuals age, attributed to brain aging and cumulative cellular damage. Synthetic cannabinoids work by targeting specific cannabinoid receptors within the brain, thereby assisting in the regulation of neurotransmitter activity and potentially mitigating symptoms linked to neurological disorders. For example, data from September 2024, provided by the European Brain Council, a health organization based in Belgium, indicates that 7 million individuals in Europe are currently living with Alzheimer’s disease. This figure is projected to rise to 14 million by 2030, driven by an aging population, thus presenting a major worldwide public health issue. Consequently, the escalating demand for neurological disorder treatments is stimulating the growth within the synthetic cannabinoids market.

What Are The Segment Types Shaping The Synthetic Cannabinoids Market?

The synthetic cannabinoids market covered in this report is segmented –

1) By Product Type: High-Pure Synthetic Cannabinoids, Ultra-Pure Synthetic Cannabinoids

2) By Formulation: Oil, Capsules, Edibles, Vapes, Topicals

3) By Indication: Pain Management, Nausea Or Vomiting, Neurological Disorder Management, Other Indications

4) By Application: Pharmaceuticals, Research, Recreational Use, Agriculture, Nutraceuticals

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By High-Pure Synthetic Cannabinoids: Pharmaceutical-Grade Cannabinoids, Research-Grade Cannabinoids, Industrial-Use Cannabinoids

2) By Ultra-Pure Synthetic Cannabinoids: Medical-Grade Cannabinoids, Biotechnology-Grade Cannabinoids, Analytical-Standard Cannabinoids

Which Market Trends Are Creating New Opportunities In The Synthetic Cannabinoids Industry?

Major companies operating in the synthetic cannabinoids market are concentrating on developing sophisticated methods, including fungal expression systems, to boost production efficiency and lower expenses. These fungal expression systems employ genetically modified fungi to create synthetic cannabinoids through biosynthesis, providing an environmentally friendly and expandable option compared to chemical synthesis or extraction from plants. Such systems allow for the production of high-purity compounds suitable for pharmaceutical and research purposes. An example of this is Dyadic International Inc., a US-based biotechnology firm, which introduced a C1-cell protein production platform in January 2022 specifically for manufacturing synthetic cannabinoids. This novel method utilizes filamentous fungal cell factories to produce cannabinoids like cannabidiol (CBD) and their precursors in a more economical and sustainable manner. The process itself is eco-friendly, energy-saving, and can yield purer, compliant cannabinoids that hold potential for therapeutic uses in conditions like chronic pain, inflammation, and various other medical ailments.

Who Are The Primary Competitors In The Global Synthetic Cannabinoids Market?

Major companies operating in the synthetic cannabinoids market are Johnson Matthey, Harmony Biosciences, BioVectra, Restek Corporation, Noramco Inc., Cayman Chemical, Cerilliant Corporation, Skye Bioscience, Purisys LLC, Chiron AS, Lygos Inc., Botanix Pharmaceuticals, CB Therapeutics Inc., BayMedica, Zynerba Pharmaceuticals Inc., Kannalife Sciences Inc., SciSparc Ltd., 180 Life Science, Tetra Bio-Pharma Inc., Canntab Therapeutics Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/synthetic-cannabinoids-global-market-report

How Is Synthetic Cannabinoids Market Demand Varying Across Different Regions?

North America was the largest region in the synthetic cannabinoids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic cannabinoids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Synthetic Cannabinoids Market Report:

https://www.thebusinessresearchcompany.com/customise?id=23536&type=smp

Browse Through More Reports Similar to the Global Synthetic Cannabinoids Market 2025, By The Business Research Company

Cannabinoids Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cannabinoids-global-market-report

Synthetic Rubber And Fibers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/synthetic-rubber-and-fibers-global-market-report

Synthetic Dyes Market 2025

https://www.thebusinessresearchcompany.com/report/synthetic-dyes-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Are The Market Size Estimates For The Synthetic Cannabinoids Market?
In recent years, an accelerated growth has been observed in the synthetic cannabinoids market’s size. The market, which is projected to expand from $1.88 billion in 2024 to $2.2 billion in 2025, is predicted to have a compound annual growth rate (CAGR) of 17.1%. Increased demand for substitute drugs, a rise in the number of cannabis users, expanding applications in the pharmaceutical industry, growing demand for legalized highs, and a trend towards self-medication are some of the factors linked with the notable growth in the historic period.

The market for synthetic cannabinoids is projected to experience significant expansion in the coming years, with a projected value of $4.19 billion by 2029, reflecting a compound annual growth rate (CAGR) of 17.5%. Factors contributing to this growth are the increasing popularity of designer drugs, more prevalent legalization of cannabis, improved online availability of synthetic drugs, a spike in the popularity of vaping, and an uptick in the customization of cannabinoid products. Key trends predicted for the forecast period include more advanced forensic toxicology practices, the application of machine learning in detecting chemical patterns, the use of cloud technology for tracking illicit drugs, breakthroughs in synthetic cannabinoid formulations, and the creation of innovative cannabinoid analogs.

Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23536&type=smp

What Drivers Are Accelerating Expansion Of The Synthetic Cannabinoids Market?
An escalating necessity for therapies for neurological conditions is anticipated to spur the expansion of the synthetic cannabinoids market in future. Neurological conditions, which affect the brain, spinal cord, and nerves, impede movement, perception, cognition, or general functioning. The surge in occurrences of these disorders is largely dependent on the maturing global populace, as diseases such as Alzheimer’s increase in prevalence with age due to the brain’s natural aging process and accumulated cellular damage. Synthetic cannabinoids interact with cannabinoid receptors in the brain, modulating neurotransmitter activity and potentially relieving symptoms correlated with neurological diseases. For example, as per data from the European Brain Council, a health organization based in Belgium, there were 7 million Alzheimer’s patients in Europe as of September 2024. This figure is expected to double to 14 million by 2030 due to an aging population, symbolizing a substantial worldwide public health obstacle. Thus, an escalating necessity for therapies for neurological conditions is the key driving force behind the expansion of the synthetic cannabinoids market.

How Is The Global Synthetic Cannabinoids Market Broken Down By Segment?
The synthetic cannabinoids market covered in this report is segmented –

1) By Product Type: High-Pure Synthetic Cannabinoids, Ultra-Pure Synthetic Cannabinoids
2) By Formulation: Oil, Capsules, Edibles, Vapes, Topicals
3) By Indication: Pain Management, Nausea Or Vomiting, Neurological Disorder Management, Other Indications
4) By Application: Pharmaceuticals, Research, Recreational Use, Agriculture, Nutraceuticals
5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:
1) By High-Pure Synthetic Cannabinoids: Pharmaceutical-Grade Cannabinoids, Research-Grade Cannabinoids, Industrial-Use Cannabinoids
2) By Ultra-Pure Synthetic Cannabinoids: Medical-Grade Cannabinoids, Biotechnology-Grade Cannabinoids, Analytical-Standard Cannabinoids

Which Trends Are Likely To Redefine Growth Paths In The Synthetic Cannabinoids Market?
Prominent firms in the synthetic cannabinoids market are concentrating on devising sophisticated solutions, like fungal expression systems, to improve the efficacy of production and curtail expenses. Genetically modified fungi are utilized in fungal expression systems to bioengineer synthetic cannabinoids, thereby presenting an environment-friendly and expandable alternative to chemical compound synthesis or extracting from plants. For pharmaceutical and research applications, these systems facilitate the production of high-purity compounds. For instance, in January 2022, Dyadic International Inc., a bio-tech firm based in the United States, presented a C1-cell protein production mechanism to generate synthetic cannabinoids. The groundbreaking approach uses filamentous fungal cell factories to produce cannabinoids like cannabidiol (CBD) and its forerunners in a more economical and sustainable manner. The method is energy-efficient and environmentally sustainable, offering the possibility of producing cleaner, regulation-compliant cannabinoids with potential therapeutic uses for medical conditions such as chronic pain, inflammation, and others.

Who Are The Global Leaders Steering The Synthetic Cannabinoids Market Forward?
Major companies operating in the synthetic cannabinoids market are Johnson Matthey, Harmony Biosciences, BioVectra, Restek Corporation, Noramco Inc., Cayman Chemical, Cerilliant Corporation, Skye Bioscience, Purisys LLC, Chiron AS, Lygos Inc., Botanix Pharmaceuticals, CB Therapeutics Inc., BayMedica, Zynerba Pharmaceuticals Inc., Kannalife Sciences Inc., SciSparc Ltd., 180 Life Science, Tetra Bio-Pharma Inc., Canntab Therapeutics Ltd.

Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/synthetic-cannabinoids-global-market-report

Which Regional Markets Are Emerging As Key Hubs For The Synthetic Cannabinoids Market?
North America was the largest region in the synthetic cannabinoids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic cannabinoids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=23536&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Are The Market Size Estimates For The Synthetic Cannabinoids Market?

In recent years, an accelerated growth has been observed in the synthetic cannabinoids market’s size. The market, which is projected to expand from $1.88 billion in 2024 to $2.2 billion in 2025, is predicted to have a compound annual growth rate (CAGR) of 17.1%. Increased demand for substitute drugs, a rise in the number of cannabis users, expanding applications in the pharmaceutical industry, growing demand for legalized highs, and a trend towards self-medication are some of the factors linked with the notable growth in the historic period.

The market for synthetic cannabinoids is projected to experience significant expansion in the coming years, with a projected value of $4.19 billion by 2029, reflecting a compound annual growth rate (CAGR) of 17.5%. Factors contributing to this growth are the increasing popularity of designer drugs, more prevalent legalization of cannabis, improved online availability of synthetic drugs, a spike in the popularity of vaping, and an uptick in the customization of cannabinoid products. Key trends predicted for the forecast period include more advanced forensic toxicology practices, the application of machine learning in detecting chemical patterns, the use of cloud technology for tracking illicit drugs, breakthroughs in synthetic cannabinoid formulations, and the creation of innovative cannabinoid analogs.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23536&type=smp

What Drivers Are Accelerating Expansion Of The Synthetic Cannabinoids Market?

An escalating necessity for therapies for neurological conditions is anticipated to spur the expansion of the synthetic cannabinoids market in future. Neurological conditions, which affect the brain, spinal cord, and nerves, impede movement, perception, cognition, or general functioning. The surge in occurrences of these disorders is largely dependent on the maturing global populace, as diseases such as Alzheimer’s increase in prevalence with age due to the brain’s natural aging process and accumulated cellular damage. Synthetic cannabinoids interact with cannabinoid receptors in the brain, modulating neurotransmitter activity and potentially relieving symptoms correlated with neurological diseases. For example, as per data from the European Brain Council, a health organization based in Belgium, there were 7 million Alzheimer’s patients in Europe as of September 2024. This figure is expected to double to 14 million by 2030 due to an aging population, symbolizing a substantial worldwide public health obstacle. Thus, an escalating necessity for therapies for neurological conditions is the key driving force behind the expansion of the synthetic cannabinoids market.

How Is The Global Synthetic Cannabinoids Market Broken Down By Segment?

The synthetic cannabinoids market covered in this report is segmented –

1) By Product Type: High-Pure Synthetic Cannabinoids, Ultra-Pure Synthetic Cannabinoids

2) By Formulation: Oil, Capsules, Edibles, Vapes, Topicals

3) By Indication: Pain Management, Nausea Or Vomiting, Neurological Disorder Management, Other Indications

4) By Application: Pharmaceuticals, Research, Recreational Use, Agriculture, Nutraceuticals

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By High-Pure Synthetic Cannabinoids: Pharmaceutical-Grade Cannabinoids, Research-Grade Cannabinoids, Industrial-Use Cannabinoids

2) By Ultra-Pure Synthetic Cannabinoids: Medical-Grade Cannabinoids, Biotechnology-Grade Cannabinoids, Analytical-Standard Cannabinoids

Which Trends Are Likely To Redefine Growth Paths In The Synthetic Cannabinoids Market?

Prominent firms in the synthetic cannabinoids market are concentrating on devising sophisticated solutions, like fungal expression systems, to improve the efficacy of production and curtail expenses. Genetically modified fungi are utilized in fungal expression systems to bioengineer synthetic cannabinoids, thereby presenting an environment-friendly and expandable alternative to chemical compound synthesis or extracting from plants. For pharmaceutical and research applications, these systems facilitate the production of high-purity compounds. For instance, in January 2022, Dyadic International Inc., a bio-tech firm based in the United States, presented a C1-cell protein production mechanism to generate synthetic cannabinoids. The groundbreaking approach uses filamentous fungal cell factories to produce cannabinoids like cannabidiol (CBD) and its forerunners in a more economical and sustainable manner. The method is energy-efficient and environmentally sustainable, offering the possibility of producing cleaner, regulation-compliant cannabinoids with potential therapeutic uses for medical conditions such as chronic pain, inflammation, and others.

Who Are The Global Leaders Steering The Synthetic Cannabinoids Market Forward?

Major companies operating in the synthetic cannabinoids market are Johnson Matthey, Harmony Biosciences, BioVectra, Restek Corporation, Noramco Inc., Cayman Chemical, Cerilliant Corporation, Skye Bioscience, Purisys LLC, Chiron AS, Lygos Inc., Botanix Pharmaceuticals, CB Therapeutics Inc., BayMedica, Zynerba Pharmaceuticals Inc., Kannalife Sciences Inc., SciSparc Ltd., 180 Life Science, Tetra Bio-Pharma Inc., Canntab Therapeutics Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/synthetic-cannabinoids-global-market-report

Which Regional Markets Are Emerging As Key Hubs For The Synthetic Cannabinoids Market?

North America was the largest region in the synthetic cannabinoids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic cannabinoids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=23536&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model